Viewing Study NCT02536495


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-04-11 @ 1:52 PM
Study NCT ID: NCT02536495
Status: WITHDRAWN
Last Update Posted: 2015-10-30
First Post: 2015-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer
Sponsor: Erin Bertino
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module